Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
RA Capital Management, L.P. | 5,330,412 9.000% |
-185,655 (-3.37%) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | UroGen Pharma Ltd. URGN |
RA Capital Management, L.P. | 3,083,558 9.990% |
8 (+0.00%) |
Filing History |
| 2024-02-14 5:01 pm Sale |
2024-02-14 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 8,197,333 9.900% |
-1,136,000 (-12.17%) |
Filing History |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | HilleVax, Inc. HLVX |
RA Capital Management, L.P. | 0 0.000% |
-1,760,019 (Position Closed) |
Filing History |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | Cogent Biosciences, Inc. COGT |
RA Capital Management, L.P. | 0 0.000% |
-5,999,481 (Position Closed) |
Filing History |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
RA Capital Management, L.P. | 0 0.000% |
-4,398,453 (Position Closed) |
Filing History |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | NanoString Technologies, Inc. NSTGQ |
RA Capital Management, L.P. | 0 0.000% |
-2,577,373 (Position Closed) |
Filing History |
| 2024-02-13 4:16 pm Purchase |
2024-02-09 | 13D | PepGen Inc. PEPG |
RA Capital Management, L.P. | 10,695,135 34.100% |
2,563,183 (+31.52%) |
Filing History |
| 2024-02-12 4:49 pm Purchase |
2024-02-12 | 13D | Mineralys Therapeutics, Inc. MLYS |
RA Capital Management, L.P. | 4,949,307 9.990% |
1,768,387 (+55.59%) |
Filing History |
| 2024-02-12 4:18 pm Purchase |
2024-02-02 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
RA Capital Management, L.P. | 430,182 4.100% |
430,182 (New Position) |
Filing History |
| 2024-02-12 4:17 pm Purchase |
2024-02-01 | 13G | Astria Therapeutics, Inc. ATXS |
RA Capital Management, L.P. | 4,413,150 8.100% |
4,413,150 (New Position) |
Filing History |
| 2024-02-06 4:40 pm Purchase |
2024-02-06 | 13D | Tyra Biosciences, Inc. TYRA |
RA Capital Management, L.P. | 10,475,489 19.990% |
3,239,035 (+44.76%) |
Filing History |
| 2024-02-05 4:30 pm Purchase |
2024-01-25 | 13G | Adicet Bio, Inc. ACET |
RA Capital Management, L.P. | 7,696,949 9.990% |
7,696,949 (New Position) |
Filing History |
| 2024-02-01 6:22 pm Purchase |
2024-01-22 | 13G | Dianthus Therapeutics, Inc. DNTH |
RA Capital Management, L.P. | 2,995,023 9.990% |
2,995,023 (New Position) |
Filing History |
| 2024-01-29 4:30 pm Purchase |
2024-01-19 | 13G | Edgewise Therapeutics, Inc. EWTX |
RA Capital Management, L.P. | 8,909,091 9.600% |
8,909,091 (New Position) |
Filing History |
| 2024-01-19 4:30 pm Purchase |
2024-01-18 | 13G | Vaxart, Inc. VXRT |
RA Capital Management, L.P. | 15,384,615 9.100% |
15,384,615 (New Position) |
Filing History |
| 2024-01-12 5:00 pm Purchase |
2024-01-02 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
RA Capital Management, L.P. | 3,073,119 8.700% |
3,073,119 (New Position) |
Filing History |
| 2024-01-11 5:24 pm Purchase |
2024-01-11 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 4,348,828 11.700% |
917,210 (+26.73%) |
Filing History |
| 2023-12-29 4:30 pm Purchase |
2023-12-19 | 13G | UroGen Pharma Ltd. URGN |
RA Capital Management, L.P. | 3,083,550 9.990% |
3,083,550 (New Position) |
Filing History |
| 2023-12-26 4:30 pm Purchase |
2023-12-14 | 13G | C4 Therapeutics, Inc. CCCC |
RA Capital Management, L.P. | 4,878,000 9.900% |
4,878,000 (New Position) |
Filing History |